Principal Investigator

Scott A. Guelcher, Ph.D.


Professor of Chemical and Bimolecular Engineering

Professor of Biomedical Engineering

Professor of Medicine

Director, Vanderbilt Center for Bone Biology

Office: Olin 412

Email address:

Phone: 615-322-9097


NIH NRSA Post-doctoral Fellow, Department of Biomedical Engineering, Carnegie Mellon University, 2003 – 2005

Ph.D. Chemical Engineering, 1999, Carnegie Mellon University

B.S. Chemical Engineering, 1992, Virginia Tech

Industrial experience:

Bayer Corporation, Polyurethanes Division 1999 – 2002

Eastman Chemical, Research Division 1992 – 1994


Scott Guelcher is a Professor of Chemical and Biomolecular Engineering, Professor of Medicine, and the Director of the Center for Bone Biology at Vanderbilt University in Nashville, TN.  Prior to his appointment at Vanderbilt, he was a Senior Associate Scientist at Bayer Corporation and an NIH/NRSA Fellow in the Department of Biomedical Engineering at Carnegie Mellon University. Professor Guelcher’s research focuses on the design and development of biomaterials and delivery systems that enhance healing of tissue damaged by trauma or disease. He collaborates with biomedical scientists and clinicians to design, develop, and scale-up new materials for bone and soft tissue regeneration from the bench to the bedside.   He also studies how the bone/tumor microenvironment regulates the progression of tumor-induced bone disease and designs new tumor-targeted therapies to block establishment of tumors in bone. Dr. Guelcher is an author on over ninety publications and an inventor on twelve patents.